Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 20, 2018Current NeuropharmacologyOpen Access

Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential

View Full Paper
Ask AI
Bookmark
Share

Authors

DFDahua FanLLLiping LiuZWZhengzhi Wu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fan et al. (2018) studied this question.

synapsesocial.com/papers/6a70e2bdce524a4339c49004https://doi.org/10.2174/1570159x16666180419141613
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Berberine-Loaded Targeted Nanoparticles as Specific<i>Helicobacter Pylori</i>Eradication Therapy:<i>In Vitro</i>and<i>In Vivo</i>Study2014 · 90 citations
  2. 2Repertoires of Autophagy in the Pathogenesis of Ocular Diseases2015 · 16,339 citations
  3. 3Pharmacological and therapeutic effects of<i>Berberis vulgaris</i>and its active constituent, berberine2008 · 640 citations
  4. 4Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microglia2010 · 148 citations
  5. 5Degradation of MDM2 by the Interaction between Berberine and DAXX Leads to Potent Apoptosis in MDM2-Overexpressing Cancer Cells2010 · 130 citations